Enzene gets DCGI nod for biosimilar drug to treat haematological disorder

[ad_1]


The symptoms of this disorder ranges from mild skin bleeding and bruises to potentially fatal internal bleeding, such as in the gastrointestinal tract and the brain.

[ad_2]

Source link